2019
1092 – Importance of Endoscopic and Histological Evaluation in the Management of Immune Checkpoint Inhibitor-Induced Colitis
Abu-Sbeih H, Ali F, Luo W, Raju G, Wang Y. 1092 – Importance of Endoscopic and Histological Evaluation in the Management of Immune Checkpoint Inhibitor-Induced Colitis. Gastroenterology 2019, 156: s-232-s-233. DOI: 10.1016/s0016-5085(19)37377-9.Peer-Reviewed Original Research
2018
The Importance of Endoscopic and Histological Evaluation in the Management of Immune Checkpoint Inhibitor-Induced Colitis
Abu-Sbeih H, Ali F, Luo W, Raju G, Wang Y. The Importance of Endoscopic and Histological Evaluation in the Management of Immune Checkpoint Inhibitor-Induced Colitis. The American Journal Of Gastroenterology 2018, 113: s112-s113. DOI: 10.14309/00000434-201810001-00197.Peer-Reviewed Original ResearchThe Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors
Tang T, Abu-Sbeih H, Luo W, Samdani R, Qiao W, Bresalier R, Richards D, Wang Y. The Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors. The American Journal Of Gastroenterology 2018, 113: s705. DOI: 10.14309/00000434-201810001-01231.Peer-Reviewed Original Research